CD38 and Parkinson disease: Even further, human‐based Mendelian randomization studies have identified single‐nucleotide polymorphisms (SNPs) in the CD38 locus that confer increased risk of PD (Chen et al. 2014; Li et al. 2019; Sharma et al. 2012; Storm et al. 2021).